Department of Dermatology, Faculty of Medicine, Cairo University, Cairo, Egypt.
J Cutan Pathol. 2022 Aug;49(8):736-742. doi: 10.1111/cup.14235. Epub 2022 Apr 27.
Cutaneous leukocytoclastic vasculitis (LCV) has been reported as a rare form of cutaneous reaction to different SARS-Cov-2 vaccines. Herein, we present the first case of cutaneous LCV following BBIBP-CorV (Sinopharm) vaccine that occurred in a female patient with no prior comorbidities. A literature review about similar cases following different COVID-19 vaccines is discussed.
皮肤白细胞碎裂性血管炎（LCV）已被报道为一种罕见的皮肤对不同 SARS-CoV-2 疫苗的反应形式。在此，我们报告了首例 BBIBP-CorV（国药）疫苗接种后发生的皮肤 LCV 病例，该病例发生于一位无既往合并症的女性患者。还对不同 COVID-19 疫苗接种后发生类似病例的文献进行了回顾。
